Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 3:18:73-90.
doi: 10.2147/JIR.S488972. eCollection 2025.

Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients

Snjezana Zeba  1 , Maja Surbatovic  2 , Ivo Udovicic  1 , Ivan Stanojevic  3 , Danilo Vojvodic  3 , Goran Rondovic  1 , Katarina Mladenovic  1 , Tanja Abazovic  2 , Almina Hasanovic  4 , Aleksandra N Ilic  5 , Dzihan Abazovic  6 , Wasim Khan  7 , Dragan Djordjevic  1
Affiliations

Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients

Snjezana Zeba et al. J Inflamm Res. .

Abstract

Purpose: The aim of the retrospective, single-center study was to assess the prognostic value of immune cell-based and albumin-based ratios regarding lethal outcome in critically ill COVID-19 patients.

Patients and methods: We analyzed 612 adult critically ill COVID-19 patients admitted to the intensive care unit (ICU) between April 2020 and November 2022. Blood measurement on admission to the ICU encompassed complete blood count (CBC), IL-6, C-reactive protein (CRP), albumin, lactate, lactate dehydrogenase (LDH), serum bicarbonate, arterial base deficit/excess (BD/E), and D-dimer. All the measured and calculated parameters were compared between survivors and nonsurvivors, with the outcome measure being hospital mortality.

Results: Immune cell-based ratios [NLR - Neutrophil-to-Lymphocyte Ratio, MLR - Monocyte-to-Lymphocyte Ratio, PLR - Platelet-to-Lymphocyte Ratio, MPV - Mean Platelet Volume, MPV/PC - Mean Platelet Volume-to-Platelet Count Ratio, Derived (d-)NLR ratio - neutrophil count divided by the result of white blood cell (WBC) count - neutrophil count), N/LP - Neutrophil count x 100/Lymphocyte count x Platelet count, CLR - C-reactive protein (CRP)-to-Lymphocyte Ratio, CPR - CRP-to-Platelet Ratio, LLR - Lactate dehydrogenase (LDH)-to-Lymphocyte Ratio, Systemic Immune Inflammation Index (SII) - platelet x neutrophil/lymphocyte count, Systemic Inflammation Response Index (SIRI) - neutrophil x monocyte/lymphocyte count] were investigated. White blood cell and neutrophil counts were significantly higher, while lymphocyte and platelet counts were significantly lower in nonsurvivors. MPV, MPV/PC, NLR, d-NLR, MLR, N/LP, CRP, LDH, CPR, CLR, LLR, SII, and SIRI values were significantly higher in nonsurvivors. Monocyte count and PLR values did not differ significantly between groups. Albumin-based ratios included CRP-to-Albumin Ratio (CAR), Lactate-to-Albumin Ratio (LAR) and LDH-to-Albumin Ratio (LDH/ALB). All values were significantly higher in nonsurvivors.

Conclusion: The only independent predictor of lethal outcomes at ICU admission is the albumin-based LDH/ALB ratio. Most of the other parameters were moderate, although highly significant predictors of mortality in critically ill COVID-19 patients.

Keywords: COVID-19; LDH/albumin ratio; critically ill; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this study.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
Receiver operating characteristic (ROC) curves of Albumin-Based Ratios, IL-6, bicarbonate, lactate, arterial B/DE and D-dimer in predicting lethal Outcomes.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curves of composite Bioscore I and II in predicting lethal outcomes.
See this image and copyright information in PMC

References

    1. Rondovic G, Djordjevic D, Udovicic I, et al. From cytokine storm to cytokine breeze: did lessons learned from immunopathogenesis improve immunomodulatory treatment of moderate-to-severe COVID-19? Biomedicines. 2022;10(10):2620. doi: 10.3390/biomedicines10102620 - DOI - PMC - PubMed
    1. Cidade JP, Coelho LM, Costa V, et al. Septic shock 3.0 criteria application in severe COVID-19 patients: an unattended sepsis population with high mortality risk. World J Crit Care Med. 2022;11(4):246–254. doi: 10.5492/wjccm.v11.i4.246 - DOI - PMC - PubMed
    1. Shankar-Hari M, Calandra T, Soares MP, et al. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies. Lancet Respir Med. 2024;12(4):323–336. doi: 10.1016/S2213-2600(23)00468-X - DOI - PMC - PubMed
    1. Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. doi: 10.1186/s13054-020-02950-2 - DOI - PMC - PubMed
    1. Djordjevic D, Rondovic G, Surbatovic M, et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm. 2018;2018:3758068. doi: 10.1155/2018/3758068 - DOI - PMC - PubMed

LinkOut - more resources